Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Apolipoprotein A5 and hypertriglyceridemia.

× No keyword cloud information.

9 in total

1. A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese.

Authors: Chao Qiang Jiang; Bin Liu; Bernard M Y Cheung; Tai Hing Lam; Jie Ming Lin; Ya Li Jin; Xiao Jun Yue; Kwok Leung Ong; Sidney Tam; Ka Sing Wong; Brian Tomlinson; Karen S L Lam; G Neil Thomas
Journal: Eur J Hum Genet Date: 2010-06-23 Impact factor: 4.246

Review 2. The complex genetic basis of plasma triglycerides.

Authors: Christopher T Johansen; Robert A Hegele
Journal: Curr Atheroscler Rep Date: 2012-06 Impact factor: 5.113

Review 3. The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.

Authors: Mahdi Garelnabi; Kenton Lor; Jun Jin; Fei Chai; Nalini Santanam
Journal: Clin Biochem Date: 2012-09-19 Impact factor: 3.281

4. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.

Authors: Xiaomin Zhang; Qibin Qi; George A Bray; Frank B Hu; Frank M Sacks; Lu Qi
Journal: Am J Clin Nutr Date: 2012-08-22 Impact factor: 7.045

5. Allelic drop-out may occur with a primer binding site polymorphism for the commonly used RFLP assay for the -1131T>C polymorphism of the Apolipoprotein AV gene.

Authors: Kirsten J Ward; Sian Ellard; Chittaranjan S Yajnik; Timothy M Frayling; Andrew T Hattersley; Prathyusha N S Venigalla; Giriraj R Chandak
Journal: Lipids Health Dis Date: 2006-05-02 Impact factor: 3.876

6. High-resolution genetic mapping in the diversity outbred mouse population identifies Apobec1 as a candidate gene for atherosclerosis.

Authors: Tangi L Smallwood; Daniel M Gatti; Pamela Quizon; George M Weinstock; Kuo-Chen Jung; Liyang Zhao; Kunjie Hua; Daniel Pomp; Brian J Bennett
Journal: G3 (Bethesda) Date: 2014-10-23 Impact factor: 3.154

7. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.

Authors: Ya-Chao Tao; Meng-Lan Wang; Dong-Bo Wu; Chen Luo; Hong Tang; En-Qiang Chen
Journal: J Transl Med Date: 2019-05-10 Impact factor: 5.531

8. DNA polymorphisms and haplotypes of apolipoprotein A5's attribution to the plasma triglyceride levels in Koreans.

Authors: Jung Ran Choi; Chung Mo Nam; Dae Ryong Kang; Sang Mi Eom; Hye Jin Lee; Chan Mi Park; Jin Woo Im; Yangsoo Jang
Journal: Yonsei Med J Date: 2007-08-31 Impact factor: 2.759

9. A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug.

Authors: Neda M Bogari; Ashwag Aljohani; Amr A Amin; Faisal A Al-Allaf; Anas Dannoun; Mohiuddin M Taher; Atalla Elsayed; Dareen Ibrahim Rednah; Osama Elkhatee; Massimo Porqueddu; Francesco Alamanni; Soud Abdulraof A Khogeer; Ahmed Fawzy
Journal: BMC Cardiovasc Disord Date: 2019-01-03 Impact factor: 2.298

9 in total